Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2006-01-01 / Leuk. Lymphoma 2006 Jan;47(1):29-37Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
/in Gastric Cancer, International Publications /von 2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-77Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
/in Gallbladder Cancer, International Publications /von 2006-01-01 / Surg. Today 2006;36(6):559-62Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
/in Chronic Virus Hepatitis, International Publications /von 2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10Genetically modified dendritic cells for therapeutic immunity
/in Dendritic Cells, International Publications /von 2006-01-01 / Tohoku J. Exp. Med. 2006 Jan;208(1):1-8Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2006-01-01 / Cytotherapy 2006;8(4):318-26Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
/in Glioblastoma, International Publications /von 2006-01-01 / Clin Neurosurg 2006;53:345-51Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2006-01-01 / Cytotherapy 2006;8(6):580-8Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
/in HIV/AIDS, International Publications /von 2006-01-01 / Immunol. Res. 2006;36(1-3):265-74
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de